Randall T. Moon, Ph.D.
University of Washington
Randall T. Moon is presently an Investigator of the Howard Hughes Medical Institute, a Professor of Pharmacology at the University of Washington School of Medicine in Seattle, as well as the William and Marilyn Conner Chair and Founding Director of the Institute for Stem Cell and Regenerative Medicine. He was approached by Arch Venture Capital to discuss ideas for starting a biotechnology company, which led to his cofounding Fate Therapeutics, now a leading stem cell company located in San Diego. Dr. Moon received his B.A. degree in Biology at New College, Sarasota, FL, and his Ph.D. in Zoology at the University of Washington. His postdoctoral work in molecular biology was conducted at Caltech. His research focuses on understanding the fundamental biology of Wnt signal transduction pathways with the long-term goal of applying this knowledge to impact medical care. Specifically, Wnts are a family of secreted proteins that activate receptor-mediated signal transduction pathways throughout life, modulating cell proliferation, cell fate, and cell behavior. When Wnt signaling is misregulated this can contribute or lead to cancer, neurodegenerative diseases, bone density disease, and other clinical conditions.